2009/883/EC: Commission Decision of 26 November 2009 approving annual and multi-annual programmes and the financial contribution from the Community for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2010 and following years (notified under document C(2009) 9131)

1 The programmes for the eradication of bovine brucellosis submitted by Spain, Italy, Malta, Cyprus, Portugal and the United Kingdom are hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests, the compensation to owners for the value of their animals slaughtered subject to those programmes and the purchase of vaccine doses, and shall not exceed: (a) EUR 2000000 for Spain; (b) EUR 5000000 for Italy; (c) EUR 75000 for Cyprus; (d) EUR 15000 for Malta; (e) EUR 2500000 for Portugal; (f) EUR 2700000 for the United Kingdom.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed: (a)for a rose bengal testEUR 0,2 per test;(b)for a SAT testEUR 0,2 per test;(c)for a complement fixation testEUR 0,4 per test;(d)for an ELISA testEUR 1 per test;(e)for animals slaughteredEUR 375 per animal.

1 The programmes for the eradication of bovine tuberculosis submitted by Ireland, Spain, Italy, Portugal and the United Kingdom are hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the costs of carrying out tuberculin and gamma-interferon tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed: (a) EUR 12000000 for Ireland; (b) EUR 7500000 for Spain; (c) EUR 4000000 for Italy; (d) EUR 1000000 for Portugal; (e) EUR 10000000 for the United Kingdom.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed: (a)for a tuberculin testEUR 1,75 per test;(b)for a gamma-interferon testEUR 5 per test;(c)for animals slaughteredEUR 375 per animal.

1 The programmes for the eradication of ovine and caprine brucellosis submitted by Spain, Italy, Cyprus and Portugal are hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the purchase of vaccines, the cost of carrying out laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed: (a) EUR 4500000 for Spain; (b) EUR 3500000 for Italy; (c) EUR 75000 for Cyprus; (d) EUR 1100000 for Portugal.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed: (a)for a rose bengal testEUR 0,2 per test;(b)for a complement fixation testEUR 0,4 per test;(c)for animals slaughteredEUR 50 per animal.

1 The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out the vaccination, the laboratory tests for virological, serological and entomological surveillance and the purchase of traps and vaccines and shall not exceed: (a) EUR 4500000 for Belgium; (b) EUR 6000 for Bulgaria; (c) EUR 1600000 for the Czech Republic; (d) EUR 50000 for Denmark; (e) EUR 16800000 for Germany; (f) EUR 130000 for Estonia; (g) EUR 80000 for Ireland; (h) EUR 70000 for Greece; (i) EUR 20000000 for Spain; (j) EUR 40000000 for France; (k) EUR 2700000 for Italy; (l) EUR 310000 for Latvia; (m) EUR 630000 for Lithuania; (n) EUR 300000 for Luxembourg; (o) EUR 780000 for Hungary; (p) EUR 4000 for Malta; (q) EUR 110000 for the Netherlands; (r) EUR 1000000 for Austria; (s) EUR 70000 for Poland; (t) EUR 5200000 for Portugal; (u) EUR 110000 for Romania; (v) EUR 590000 for Slovenia; (w) EUR 50000 for Slovakia; (x) EUR 490000 for Finland; (y) EUR 1700000 for Sweden.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed: (a) for an ELISA testEUR 2,5 per test; (b) for a PCR testEUR 10 per test; (c) for the purchase of monovalent vaccinesEUR 0,3 per dose; (d) for the purchase of bivalent vaccinesEUR 0,45 per dose; (e) for the administration of vaccines to bovine animals EUR 1,50 per bovine animal vaccinated, regardless of the number and types of doses used; (f) for the administration of vaccines to ovine or caprine animals EUR 0,75 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.

1 The programmes for the control of certain zoonotic salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Estonia, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovakia, Slovenia and the United Kingdom are hereby approved for the period from 1 January to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out bacteriological and serotyping tests in the framework of official sampling, bacteriological tests to verify the efficiency of disinfection, tests for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for Salmonella, the purchase of vaccine doses and the compensation to owners for the value of the culled breeding and laying birds of Gallus gallus and culled breeding turkey birds of Meleagris gallopavo and for destroyed eggs as specified in paragraph 3 and shall not exceed: (a) EUR 2000000 for Belgium; (b) EUR 20000 for Bulgaria; (c) EUR 2500000 for the Czech Republic; (d) EUR 200000 for Denmark; (e) EUR 15000 for Estonia; (f) EUR 800000 for Germany; (g) EUR 100000 for Ireland; (h) EUR 550000 for Greece; (i) EUR 2500000 for Spain; (j) EUR 3500000 for France; (k) EUR 1250000 for Italy; (l) EUR 100000 for Cyprus; (m) EUR 420000 for Latvia; (n) EUR 160000 for Lithuania; (o) EUR 10000 for Luxembourg; (p) EUR 2500000 for Hungary; (q) EUR 150000 for Malta; (r) EUR 3500000 for the Netherlands; (s) EUR 960000 for Austria; (t) EUR 3500000 for Poland; (u) EUR 255000 for Portugal; (v) EUR 600000 for Romania; (w) EUR 117000 for Slovenia; (x) EUR 730000 for Slovakia; (y) EUR 52000 for the United Kingdom.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed: (a) for a bacteriological test (cultivation/isolation) EUR 5,0 per test; (b) for the purchase of Salmonella vaccine dose EUR 0,05 per dose; (c) for serotyping of relevant isolates of Salmonella spp. EUR 20 per test; (d) for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a Salmonella-positive flock EUR 5,0 per test; (e) for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for Salmonella EUR 5 per test; (f) for the compensation for the value of a parent breeding bird of Gallus gallus culled, EUR 4 per bird; (g) for the compensation for the value of a commercial laying bird of Gallus gallus culled, EUR 2,20 per bird; (h) for the compensation for the value of a parent breeding turkey bird of Meleagris gallopavo culled, EUR 12 per bird; (i) for the compensation for hatching eggs of parent breeding Gallus gallus, EUR 0,20 per hatching egg destroyed; (j) for the compensation for table eggs of Gallus gallus EUR 0,04 per table egg destroyed; (k) for the compensation for hatching eggs of parent breeding Meleagris gallopavo, EUR 0,40 per hatching egg destroyed;

1 The programmes for the control and monitoring of: (a) Classical swine fever submitted by Bulgaria, Germany, France, Luxembourg, Hungary, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January 2010 to 31 December 2010; (b) African swine fever submitted by Italy is hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out virological and serological tests of domestic pigs and wild boars and for the programmes submitted by Bulgaria, Germany, France, Romania and Slovakia also at the rate of 50 % of the costs to be incurred for the purchase and distribution of vaccines plus baits for the vaccination of wild boars and shall not exceed: (a) EUR 240000 for Bulgaria; (b) EUR 1400000 for Germany; (c) EUR 720000 for France; (d) EUR 110000 for Italy; (e) EUR 25000 for Luxembourg (f) EUR 300000 for Hungary; (g) EUR 1200000 for Romania; (h) EUR 30000 for Slovenia; (i) EUR 515000 for Slovakia.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed for an ELISA test EUR 2,5 per test.

1 The programme for the eradication of swine vesicular disease submitted by Italy is hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the cost of laboratory tests and shall not exceed EUR 450000.

1 The survey programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests and a lump sum for sampling of wild birds, and shall not exceed: (a) EUR 135000 for Belgium; (b) EUR 50000 from Bulgaria; (c) EUR 85000 for the Czech Republic; (d) EUR 200000 for Denmark; (e) EUR 350000 for Germany; (f) EUR 10000 for Estonia; (g) EUR 110000 for Ireland; (h) EUR 70000 for Greece; (i) EUR 300000 for Spain; (j) EUR 250000 for France; (k) EUR 650000 for Italy; (l) EUR 20000 for Cyprus; (m) EUR 60000 for Latvia; (n) EUR for 10000 Luxembourg; (o) EUR 300000 for Hungary; (p) EUR 10000 for Malta; (q) EUR 350000 for the Netherlands; (r) EUR 55000 for Austria; (s) EUR 100000 for Poland; (t) EUR 200000 for Portugal; (u) EUR 400000 for Romania; (v) EUR 40000 for Slovenia; (w) EUR 35000 for Slovakia; (x) EUR 35000 for Finland; (y) EUR 200000 for Sweden; (z) EUR 300000 for the United Kingdom.

3 The maximum of the costs to be reimbursed to the Member States for the tests/sampling covered by the programmes shall on average not exceed: (a)ELISA testEUR 2 per test;(b)agar gel immune diffusion testEUR 1,2 per test;(c)HI test for H5/H7EUR 12 per test;(d)virus isolation testEUR 40 per test;(e)PCR testEUR 20 per test;(f)sampling wild birdsEUR 20 per sample.

1 The programmes for the monitoring of transmissible spongiform encephalopathies (TSE), and for the eradication of bovine spongiform encephalopathy (BSE) and of scrapie submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, and the United Kingdom are hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for carrying out rapid tests in animals as referred to in Annex III Chapter A Parts I and II points 1 to 5 to Regulation (EC) No 999/2001 and in Annex VII to that Regulation, confirmatory tests and primary molecular discriminatory tests as referred to in Annex X Chapter C point 3(2)(c) (i) to Regulation (EC) No 999/2001 and at the rate of 50 % of the cost incurred by each Member State for the compensation to owners for the value of their animals culled and destroyed in accordance with their BSE and scrapie eradication programmes and at a rate of 50 % of the cost of the analysis of samples for genotyping, and shall not exceed: (a) EUR 1670000 for Belgium; (b) EUR 720000 for Bulgaria; (c) EUR 900000 for the Czech Republic; (d) EUR 1000000 for Denmark; (e) EUR 7810000 for Germany; (f) EUR 200000 for Estonia; (g) EUR 3570000 for Ireland; (h) EUR 2000000 for Greece; (i) EUR 5300000 for Spain; (j) EUR 12500000 for France; (k) EUR 6000000 for Italy; (l) EUR 50000 for Cyprus; (m) EUR 240000 for Latvia; (n) EUR 460000 for Lithuania; (o) EUR 75000 for Luxembourg; (p) EUR 1150000 for Hungary; (q) EUR 20000 for Malta; (r) EUR 2500000 for the Netherlands; (s) EUR 1010000 for Austria; (t) EUR 3100000 for Poland; (u) EUR 1350000 for Portugal; (v) EUR 1000000 for Romania; (w) EUR 180000 for Slovenia; (x) EUR 650000 for Slovakia; (y) EUR 410000 for Finland; (z) EUR 650000 for Sweden; (za) EUR 4700000 for the United Kingdom.

3 The financial contribution by the Community to the programmes referred to in paragraph 1 shall be for the tests performed and for the animals culled and destroyed and the maximum amount shall on average not exceed: (a)for tests carried out in bovine animalsEUR 5 per test;(b)for tests carried out in ovine and caprine animalsEUR 30 per test;(c)for confirmatory and primary molecular discriminatory testsEUR 175 per test;(d)per genotyping testEUR 10;(e)per culled bovine animalEUR 500;(f)per culled sheep or goatEUR 70.

1 The programmes for the eradication of rabies submitted by Bulgaria, Hungary, Poland, Romania and Slovakia are hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the characterisation of rabies virus, the detection of biomarker and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed, (a) EUR 820000 for Bulgaria; (b) EUR 880000 for Hungary; (c) EUR 4100000 for Poland; (d) EUR 1800000 for Romania; (e) EUR 370000 for Slovakia.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed: (a)for an ELISA testEUR 8 per test;(b)for a test to detect tetracycline in boneEUR 8 per test;(c)for a fluorescent antibody test (FAT)EUR 12 per test.

1 The programmes for the eradication of enzootic bovine leucosis submitted by Estonia, Lithuania, Malta and Poland are hereby approved for the period from 1 January to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed EUR: (a) EUR 20000 for Estonia; (b) EUR 20000 for Lithuania; (c) EUR 500000 for Malta; (d) EUR 1400000 for Poland.

3 The maximum of the costs to be reimbursed to the Member States for the programme referred to in paragraph 1 shall on average not exceed: (a)for an ELISA testEUR 0,5 per test;(b)for an agar gel immune diffusion testEUR 0,5 per test;(c)for an animal slaughteredEUR 375 per animal.

1 The programmes for the eradication of Aujeszky’s disease submitted by Bulgaria, Spain, Hungary and Poland are hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community to the programmes referred to in paragraph 1 shall be at the rate of 50 % of the costs to be incurred by the concerned Member State for the cost of laboratory tests, and shall not exceed: (a) EUR 25000 for Bulgaria; (b) EUR 122000 for Hungary; (c) EUR 3764000 for Poland; (d) EUR 870000 for Spain.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed for an ELISA test EUR 1 per test.

1 The multi-annual programmes for the eradication of rabies submitted by Lithuania and Austria are hereby approved for the period from 1 January 2010 to 31 December 2012.

2 The third year of the multi-annual programmes for the eradication of rabies submitted by Estonia, Latvia, Slovenia, and Finland are hereby approved for the period from 1 January 2010 to 31 December 2010.

3 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraphs 1 and 2 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the characterisation of rabies virus, the detection of biomarker, age determination and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes and shall not exceed: (a) EUR 950000 for Estonia; (b) EUR 1130000 for Latvia; (c) EUR 1000000 for Lithuania; (d) EUR 110000 for Austria (e) EUR 550000 for Slovenia; (f) EUR 100000 for Finland.

4 The maximum of the costs to be reimbursed to the concerned Member State for the programmes referred to in paragraph 1 shall on average not exceed: (a)for an ELISA testEUR 8 per test;(b)for a test to detect tetracycline in boneEUR 8 per test;(c)for a fluorescent antibody test (FAT)EUR 12 per test.

5 The amounts to be committed for the following years shall be decided in function of the execution of the programme in 2010.

1 The third year of the multi-annual programme for the eradication of Aujeszky’s disease submitted by Belgium is hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the cost to be incurred by Belgium of carrying out laboratory tests and shall not exceed EUR 262000.

3 The maximum of the costs to be reimbursed to Belgium for the programme referred to in paragraph 1 shall on average not exceed for an ELISA test EUR 1 per test.

1 The second year of the multi-annual programmes for the eradication of enzootic bovine leucosis submitted by Italy, Latvia, and Portugal is hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests and compensation to owners for the value of their animals slaughtered subject to those programmes and shall not exceed: (a) EUR 800000 for Italy; (b) EUR 55000 for Latvia; (c) EUR 750000 for Portugal.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed: (a)for an ELISA testEUR 0,5 per test;(b)for an agar gel immune diffusion testEUR 0,5 per test;(c)for animals slaughteredEUR 375 per animal.

1 The second year of the multi-annual programme for the monitoring and eradication of scrapie submitted by Cyprus on 18 March 2009 is hereby approved for the period from 1 January 2010 to 31 December 2010.

2 The financial contribution by the Community shall not exceed EUR 8200000 and shall be at the rate of: (a) 100 % of the costs to be incurred by Cyprus for carrying out rapid tests referred to in Annex III Chapter A Part II points 1 to 5 to Regulation (EC) No 999/2001 and Annex VII thereto and primary molecular discriminatory tests as referred to in Annex X Chapter C point 3.2(c)(i) to Regulation (EC) No 999/2001; (b) 75 % of the cost incurred by Cyprus for the compensation to owners for the value of their animals culled and destroyed in accordance with its programme for monitoring and eradication of scrapie; (c) 50 % of the costs of: (i) the analysis of samples for genotyping; (ii) the purchase of preparations used for euthanizing the animals; (iii) personnel specifically hired for carrying out tasks within the programme; (iv) destruction of the carcasses.

3 The maximum of the costs to be reimbursed to Cyprus for the programme referred to in paragraph 1 shall on average not exceed: (a)for tests carried out in ovine and caprine animalsEUR 30 per test;(b)for primary molecular discriminatory tests carried outEUR 175 per test;(c)for genotyping testsEUR 10 per test;(d)for culled sheep or goatsEUR 100 per animal.

The compensation to the owners for the value of the animals culled or slaughtered and of the destroyed products shall be granted within 90 days after the slaughter or culling of the animal or the destruction of the products or after the presentation of the completed claim by the owner. Article 9(1), (2) and (3) of Commission Regulation (EC) No 883/2006 shall apply to compensation payments made outside of the 90 days.

1 The expenditure submitted by the Member States for a financial contribution by the Community shall be expressed in euro and shall exclude value added tax and other taxes.

2 Where a Member State’s expenditure is in a currency other than the euro, the Member State concerned shall convert it into euro by applying the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State.

1 The financial contribution by the Community for the programmes referred to in Articles 1 to 16 shall be granted provided that the Member States concerned: (a) implement the programmes in accordance with the relevant provisions of Community law, including rules on competition and on the award of public contracts; (b) bring into force by 1 January 2010 at the latest the laws, regulations and administrative provisions necessary for implementing the programmes referred to in Articles 1 to 16; (c) forward to the Commission by 31 July 2010 at the latest the intermediate technical and financial reports for the programmes referred to in Articles 1 to 16, in accordance with Article 27(7)(a) of Decision 2009/470/EC; (d) for the programmes referred to in Article 8, report to the Commission the positive and negative results of investigations detected during their surveillance of poultry and wild birds through the Commission on-line system, every three months, by forwarding those results within a period of four weeks following the end of the month covered by the report; (e) for the programmes referred to in Articles 1 to 16, forward a final report to the Commission in accordance with Article 27(7)(b) of Decision 2009/470/EC by 30 April 2011 at the latest on the technical execution of the programme accompanied by justifying evidence as to the costs paid by the Member State and the results attained during the period from 1 January 2010 to 31 December 2010; (f) for programmes referred to in Articles 1 to 16, implement the programme efficiently; (g) do not, for the programmes referred to in Articles 1 to 16, submit further requests for other Community contributions for these measures, and have not previously submitted such requests.

2 Where a Member State does not comply with paragraph 1, the Commission shall reduce the financial contribution by the Community having regard to the nature and gravity of the infringement, and to the financial loss for the Community.

This Decision shall apply from 1 January 2010.

This Decision is addressed to the Member States.